|
|
Thursday,
June 16, 2016
4:00-7:00 pm
Program followed by a networking reception.
|
|
Nutter
155 Seaport Blvd.
5th Floor,
Louis D. Brandeis Conference Center
Boston, MA 02210
|
|
|
|
Let\’s Make a Deal:
A Look Behind the Curtain
in Life Sciences
Strategic Funding Transactions
|
|
A Life Sciences Executive Panel
Co-hosted by Nutter and Halloran Consulting
|
|
The past several years have been a booming time for life sciences. The IPO market has been remarkable and VC money has been flowing vigorously through the entire ecosystem. The times, however, are changing, necessitating an approach other than an IPO — such as a transaction with a strategic partner.
|
- What are the options for funding?
- How do leading large companies approach the relationship building and deal making?
- What goes on behind the scenes?
- How do you select the right company for a strategic relationship?
|
|
This executive panel will address the leading funding models and give attendees an unprecedented opportunity to take a look behind deal-making. The panelists will discuss working within very different models for strategically identifying and seeking technologies to meet their corporation\’s objectives in the life sciences space, and take questions from the audience.
|
|
Carolyn Green
Executive Director, Strategic Investments
Pfizer Worldwide R&D
Luba Greenwood
Vice President, Global Mergers & Acquisitions and Business Development
Roche Diagnostics
Ivana Magovcevic-Liebisch
Senior Vice President, Head of Corporate Business Development
Teva Pharmaceuticals
Michal Preminger
Executive Director, Office of Technology Development
Harvard University
|
|
Michelle Basil
Life Sciences Chair
Nutter
|
|
Who Should Attend:
- Founders, executives and board members of life sciences companies exploring partnering options
- Corporate venture investors
- Venture capital investors
- Pharmaceutical and biotechnology business development professionals
- University/Research Technology Licensing Managers
|
|
|
